Sec Form 13G Filing - Invus Public Equities, L.P. filing for Inventiva S.A. (IVA) - 2025-03-31

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Reflects ownership as of the filing date. As of October 17, 2024, Invus Public Equities, L.P. directly held 7,182,792 Ordinary shares, nominal value Euro 0.01 per share (the "Shares") of Inventiva S.A. (the "Issuer"). There is no CUSIP number assigned to the Shares. The CUSIP Number 46124U107 has been assigned to the American Depositary Shares ("ADS") of the Issuer, which are quoted on the Nasdaq Global Market under the symbol "IVA". Each ADS represents 1 Share.


SCHEDULE 13G



Comment for Type of Reporting Person:  Reflects ownership as of the filing date. As of October 17, 2024, Invus Public Equities, L.P. directly held 7,182,792 Ordinary shares, nominal value Euro 0.01 per share (the "Shares") of Inventiva S.A. (the "Issuer"). There is no CUSIP number assigned to the Shares. The CUSIP Number 46124U107 has been assigned to the American Depositary Shares ("ADS") of the Issuer, which are quoted on the Nasdaq Global Market under the symbol "IVA". Each ADS represents 1 Share.


SCHEDULE 13G



Comment for Type of Reporting Person:  Reflects ownership as of the filing date. As of October 17, 2024, Invus Public Equities, L.P. directly held 7,182,792 Ordinary shares, nominal value Euro 0.01 per share (the "Shares") of Inventiva S.A. (the "Issuer"). There is no CUSIP number assigned to the Shares. The CUSIP Number 46124U107 has been assigned to the American Depositary Shares ("ADS") of the Issuer, which are quoted on the Nasdaq Global Market under the symbol "IVA". Each ADS represents 1 Share.


SCHEDULE 13G



Comment for Type of Reporting Person:  Reflects ownership as of the filing date. As of October 17, 2024, Invus Public Equities, L.P. directly held 7,182,792 Ordinary shares, nominal value Euro 0.01 per share (the "Shares") of Inventiva S.A. (the "Issuer"). There is no CUSIP number assigned to the Shares. The CUSIP Number 46124U107 has been assigned to the American Depositary Shares ("ADS") of the Issuer, which are quoted on the Nasdaq Global Market under the symbol "IVA". Each ADS represents 1 Share.


SCHEDULE 13G



Comment for Type of Reporting Person:  Reflects ownership as of the filing date. As of October 17, 2024, Invus Public Equities, L.P. directly held 7,182,792 Ordinary shares, nominal value Euro 0.01 per share (the "Shares") of Inventiva S.A. (the "Issuer"). There is no CUSIP number assigned to the Shares. The CUSIP Number 46124U107 has been assigned to the American Depositary Shares ("ADS") of the Issuer, which are quoted on the Nasdaq Global Market under the symbol "IVA". Each ADS represents 1 Share.


SCHEDULE 13G


 
Invus Public Equities, L.P.
 
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President, Invus Public Equities Advisors, LLC, its general partner
Date:03/31/2025
 
Invus Public Equities Advisors, LLC
 
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:03/31/2025
 
Invus Global Management, LLC
 
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:03/31/2025
 
Siren, L.L.C.
 
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane, President
Date:03/31/2025
 
Raymond Debbane
 
Signature:/s/ Raymond Debbane
Name/Title:Raymond Debbane
Date:03/31/2025
Exhibit Information

ExhibitNumberTitle99.1.Joint Filing Agreement

primary_doc.xml